Identification of causative gene variants as seen in phosphatase and tensin homolog (PTEN) is an important source of information to guide treatment, surveillance, and counseling to manage comorbidities and health-related risks, such as seizures, developmental regression, and cancer. This evidence concerns the gene PTEN and cancer.